WMS 2020 Virtual Congress Industry Symposia

We are delighted to introduce a dedicated day in the WMS 2020 Virtual Congress Programme for our WMS Industry Symposia.

---

WMS Industry Symposia 1 – Antisense oligonucleotides for the treatment of neuromuscular diseases, Biogen

---

WMS Industry Symposia 2 – Duchenne muscular dystrophy: The role of real-world evidence in transforming the therapeutic outlook, PTC Therapeutics

---

WMS Industry Symposia 3 – Identify, Treat & Follow: Role of Gene Therapy in Spinal Muscular Atrophy (SMA), AveXis

---

WMS Industry Symposia 4 – Insights on the Neuromuscular and Respiratory Impairments in Pompe Disease, Sanofi Genzyme

---

WMS Industry Symposia 5 – The New Era of Gene Transfer Therapies and Application to Duchenne Muscular Dystrophy and Limb Girdle Muscular Dystrophies, Sarepta Therapeutics

---

WMS Industry Symposia 6 – Beyond motor function improvements: what is meaningful for people living with SMA?, Roche

---

The schedule for the day is as follows:


Monday 28th September 2020

---

15:00-16:30 BST WMS Industry Symposia 1 and 2
(2 x 90 minute parallel sessions incorporating live Q&A)

---

17:00 – 18:30 BST WMS Industry Symposia 3 and 4
(2 x 90 minute parallel sessions incorporating live Q&A)

---

19:00 – 20:30 BST WMS Industry Symposia 5 and 6
(2 x 90 minute parallel sessions incorporating live Q&A)

---

Please note:
- All times stated in the programme are in British Summer Time (BST)
- CME points are not available for the WMS Industry Day